Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

American Cannabis Company, Inc. Announces It Has Secured A Contract With A New Client In California


Posted on: 04 Jan 18

DENVER, CO, Jan. 17, 2018 (GLOBE NEWSWIRE) -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, today announced that it has secured a consulting contract with Cloud 9 Apothecary in the state of California. In conjunction with the consulting agreement, ACC will acquire an equity stake in Cloud 9’s project that is currently non-operational and in the development stage.

This project, to be built-out and completed in Desert Springs, California, will comprise a closed-loop greenhouse containing a 22,000 square foot canopy of premium cannabis cultivars. With the construction of this facility, Cloud 9 Apothecary’s plans focus on wholesale cultivation and product manufacturing. Plans to shift into a fully integrated business model, complete with dispensing solutions, will be made in the near future as Cloud 9 plans to scale up operations organically.

Remington Hudson, Cloud 9’s CEO commented: “Our mission is to be the apex provider of premium cannabis flower products in the state of California. All of our products are grown and developed to ensure that dispensaries consistently receive premium, healthy, organic cannabis products. We are committed to being the state's leader in quality, compliance, innovation, cutting-edge equipment, and social responsibility. Strategic partnerships are something we believe will catapult Cloud 9 Apothecary into a statewide and national brand. These are a few of many reasons we partnered with American Cannabis Company; we are proud and confident that our partnership with ACC will be successful.”

Terry Buffalo, CEO of American Cannabis Company, commented: “ACC is very happy to have joined forces with Cloud 9 Apothecary as the California market continues to bloom. Our company will work to ensure that this client group has the tools that it needs to thrive in this competitive marketplace. In taking an equity position with Cloud 9, ACC aims to be a long-term service and solution provider in an effort to continually expand the footprint of their business model.”

About American Cannabis Company, Inc.

American Cannabis Company, Inc. offers end-to-end solutions to existing and aspiring participants in the cannabis industry. We utilize our industry expertise to provide business planning and market assessment services, assist state licensing procurement, create business infrastructure and operational best practices. American Cannabis Company also developed and owns a portfolio of branded products including: The Satchel™, SoHum Living Soils™, The Cultivation Cube™ and the High-Density Cultivation System™. We also design and provide other industry-specific custom product solutions. The building and development of our brands and product suite are based on our Geoponics Philosophy, "the art and science of agriculture in soil."

For more information, please visit:

www.americancannabisconsulting.com
www.americancannabiscompanyinc.com
www.americancannabiscompany.co
www.sohumsoils.com

Forward-Looking Statements

This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs, and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations, and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

CONTACT: Contact: IR@americancannabisconsulting.com 303-974-4770 GlobeNewswire
globenewswire.com

Last updated on: 18/01/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.